Order Now: brent@sdlifesciences.com
 Cdx2 Polyclonal Antibody |
|
ABP53475-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
|
|
Description: A polyclonal antibody for detection of Cdx2 from Human, Mouse, Rat. This Cdx2 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Cdx2 at AA rangle: 20-100 |
Cdx2 Polyclonal Antibody |
|
ABP53475-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
|
|
Description: A polyclonal antibody for detection of Cdx2 from Human, Mouse, Rat. This Cdx2 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Cdx2 at AA rangle: 20-100 |
Cdx2 Polyclonal Antibody |
|
ABP53475-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
|
|
Description: A polyclonal antibody for detection of Cdx2 from Human, Mouse, Rat. This Cdx2 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Cdx2 at AA rangle: 20-100 |
Cdx2 Polyclonal Antibody |
|
ES4473-100ul |
ELK Biotech |
100ul |
EUR 334.8 |
|
Description: A Rabbit Polyclonal antibody against Cdx2 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
Cdx2 Polyclonal Antibody |
|
ES4473-50ul |
ELK Biotech |
50ul |
EUR 248.4 |
|
Description: A Rabbit Polyclonal antibody against Cdx2 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
Cdx2 Polyclonal Antibody |
|
ES4474-100ul |
ELK Biotech |
100ul |
EUR 334.8 |
|
Description: A Rabbit Polyclonal antibody against Cdx2 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
Cdx2 Polyclonal Antibody |
|
ES4474-50ul |
ELK Biotech |
50ul |
EUR 248.4 |
|
Description: A Rabbit Polyclonal antibody against Cdx2 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
Cdx2 Polyclonal Antibody |
|
ES8535-100ul |
ELK Biotech |
100ul |
EUR 334.8 |
|
Description: A Rabbit Polyclonal antibody against Cdx2 from Human/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
Cdx2 Polyclonal Antibody |
|
ES8535-50ul |
ELK Biotech |
50ul |
EUR 248.4 |
|
Description: A Rabbit Polyclonal antibody against Cdx2 from Human/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
 Polyclonal CDX2 Antibody |
|
APR06604G |
Leading Biology |
0.1 mg |
EUR 790.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CDX2 . This antibody is tested and proven to work in the following applications: |
 CDX2 Rabbit pAb |
|
A0804-100ul |
Abclonal |
100 ul |
EUR 369.6 |
CDX2 Rabbit pAb |
|
A0804-200ul |
Abclonal |
200 ul |
EUR 550.8 |
CDX2 Rabbit pAb |
|
A0804-20ul |
Abclonal |
20 ul |
EUR 219.6 |
CDX2 Rabbit pAb |
|
A0804-50ul |
Abclonal |
50 ul |
EUR 267.6 |
CDX2 Rabbit pAb |
|
A1629-100ul |
Abclonal |
100 ul |
EUR 369.6 |
CDX2 Rabbit pAb |
|
A1629-200ul |
Abclonal |
200 ul |
EUR 550.8 |
CDX2 Rabbit pAb |
|
A1629-20ul |
Abclonal |
20 ul |
EUR 219.6 |
CDX2 Rabbit pAb |
|
A1629-50ul |
Abclonal |
50 ul |
EUR 267.6 |
 CDX2 Rabbit mAb |
|
A19030-100ul |
Abclonal |
100 ul |
EUR 492 |
CDX2 Rabbit mAb |
|
A19030-200ul |
Abclonal |
200 ul |
EUR 685.2 |
CDX2 Rabbit mAb |
|
A19030-20ul |
Abclonal |
20 ul |
EUR 265.2 |
CDX2 Rabbit mAb |
|
A19030-50ul |
Abclonal |
50 ul |
EUR 344.4 |
 Anti-CDX2 Rabbit Monoclonal Antibody |
|
M00877-1 |
BosterBio |
100ug/vial |
EUR 476.4 |
|
Description: Rabbit Monoclonal CDX2 Antibody. Validated in IF, IHC, WB and tested in Human. |
 ELISA Kit) Human Caudal Type Homeobox Transcription Factor 2 (CDX2) ELISA Kit |
|
DLR-CDX2-Hu-48T |
DL Develop |
48T |
EUR 620.4 |
|
|
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Caudal Type Homeobox Transcription Factor 2 (CDX2) in samples from tissue homogenates, cell lysates or other biological fluids. |
Human Caudal Type Homeobox Transcription Factor 2 (CDX2) ELISA Kit |
|
DLR-CDX2-Hu-96T |
DL Develop |
96T |
EUR 807.6 |
|
|
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Caudal Type Homeobox Transcription Factor 2 (CDX2) in samples from tissue homogenates, cell lysates or other biological fluids. |
Human Caudal Type Homeobox Transcription Factor 2 (CDX2) ELISA Kit |
|
RDR-CDX2-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 652.8 |
Human Caudal Type Homeobox Transcription Factor 2 (CDX2) ELISA Kit |
|
RDR-CDX2-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 907.2 |
Human Caudal Type Homeobox Transcription Factor 2 (CDX2) ELISA Kit |
|
RD-CDX2-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 625.2 |
Human Caudal Type Homeobox Transcription Factor 2 (CDX2) ELISA Kit |
|
RD-CDX2-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 867.6 |
 Rabbit CDX2 ELISA Kit |
|
ERTC0591 |
Abclonal |
96Tests |
EUR 625.2 |
 CDX2 Antibody |
|
CSB-PA193119- |
Cusabio |
|
EUR 402 |
|
|
|
Description: A polyclonal antibody against CDX2. Recognizes CDX2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000 |
CDX2 Antibody |
|
CSB-PA193119-100ul |
Cusabio |
100ul |
EUR 379.2 |
|
|
|
Description: A polyclonal antibody against CDX2. Recognizes CDX2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000 |
CDX2 Antibody |
|
CSB-PA448948- |
Cusabio |
|
EUR 402 |
|
|
|
Description: A polyclonal antibody against CDX2. Recognizes CDX2 from Human, Mouse, Rat, Monkey. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000 |
CDX2 Antibody |
|
CSB-PA448948-100ul |
Cusabio |
100ul |
EUR 379.2 |
|
|
|
Description: A polyclonal antibody against CDX2. Recognizes CDX2 from Human, Mouse, Rat, Monkey. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000 |
CDX2 Antibody |
|
1-CSB-PA11699A0Rb |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against CDX2. Recognizes CDX2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA |
CDX2 Antibody |
|
1-CSB-PA006520 |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against CDX2. Recognizes CDX2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/5000 |
CDX2 Antibody |
|
1-CSB-PA559486 |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against CDX2. Recognizes CDX2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100 |
CDX2 Antibody |
|
1-CSB-PA905610 |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against CDX2. Recognizes CDX2 from Human, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1:500-10000, ELISA:1:10000 |
 CDX2 antibody |
|
70R-49533 |
Fitzgerald |
100 ul |
EUR 292.8 |
|
Description: Purified Polyclonal CDX2 antibody |
CDX2 antibody |
|
70R-34482 |
Fitzgerald |
100 ug |
EUR 392.4 |
|
Description: Rabbit polyclonal CDX2 antibody |
CDX2 Antibody |
|
48729-100ul |
SAB |
100ul |
EUR 399.6 |
CDX2 Antibody |
|
48729-50ul |
SAB |
50ul |
EUR 286.8 |
CDX2 Antibody |
|
43449-100ul |
SAB |
100ul |
EUR 302.4 |
CDX2 Antibody |
|
5595-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
|
|
Description: CDX2 Antibody: CDX2 is a member of the caudal homeobox family of transcription factors that also includes the proteins CDX1 and CDX4. CDX2 is strongly expressed in the trophectoderm in the blastocyst with expression maintained within the proliferating extra-embryonic ectoderm during development. It is required for the repression of the transcription of the POU5F1/Oct4 and NANOG genes in the outer cells of the blastocyst and is thus essential for the segregation of the inner cell mass and trophectoderm at the blastocyst stage. Aberrant expression of CDX2 is associated with numerous types of carcinomas, including intestinal metaplasia, gastric carcinoma, and acute myeloid leukemia due to deregulated HOX gene expression. |
CDX2 Antibody |
|
5595-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
|
|
Description: CDX2 Antibody: CDX2 is a member of the caudal homeobox family of transcription factors that also includes the proteins CDX1 and CDX4. CDX2 is strongly expressed in the trophectoderm in the blastocyst with expression maintained within the proliferating extra-embryonic ectoderm during development. It is required for the repression of the transcription of the POU5F1/Oct4 and NANOG genes in the outer cells of the blastocyst and is thus essential for the segregation of the inner cell mass and trophectoderm at the blastocyst stage. Aberrant expression of CDX2 is associated with numerous types of carcinomas, including intestinal metaplasia, gastric carcinoma, and acute myeloid leukemia due to deregulated HOX gene expression. |
CDX2 antibody |
|
38270-100ul |
SAB |
100ul |
EUR 302.4 |
 Cdx2 antibody |
|
20R-2758 |
Fitzgerald |
50 ug |
EUR 337.2 |
|
Description: Rabbit polyclonal Cdx2 antibody |
 Cdx2 Antibody |
|
21644-100ul |
SAB |
100ul |
EUR 302.4 |
Cdx2 Antibody |
|
21644-50ul |
SAB |
50ul |
EUR 224.4 |
CDX2 Antibody |
|
25050-100ul |
SAB |
100ul |
EUR 468 |
CDX2 Antibody |
|
35198-100ul |
SAB |
100ul |
EUR 302.4 |
CDX2 Antibody |
|
35198-50ul |
SAB |
50ul |
EUR 224.4 |
CDX2 Antibody |
|
V8310-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Involved in the transcriptional regulation of multiple genes expressed in the intestinal epithelium. Important in broad range of functions from early differentiation to maintenance of the intestinal epithelial lining of both the small and large intestine. Binds preferentially to methylated DNA. [UniProt] |
CDX2 Antibody |
|
V8310-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: Involved in the transcriptional regulation of multiple genes expressed in the intestinal epithelium. Important in broad range of functions from early differentiation to maintenance of the intestinal epithelial lining of both the small and large intestine. Binds preferentially to methylated DNA. [UniProt] |
CDX2 Antibody |
|
V8310SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Involved in the transcriptional regulation of multiple genes expressed in the intestinal epithelium. Important in broad range of functions from early differentiation to maintenance of the intestinal epithelial lining of both the small and large intestine. Binds preferentially to methylated DNA. [UniProt] |
CDX2 Antibody |
|
V8501-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: The specificity of this monoclonal antibody to its intended target was validated by HuProtTMArray, containing more than 19,000, full-length human proteins.The intestine-specific transcription factors CDX1 and CDX2 are important for directing intestinal development, differentiation, proliferation and maintenance of the intestinal phenotype. CDX2 protein expression has been seen in GI carcinomas. Anti-CDX2 has been useful to establish GI origin of metastatic adenocarcinomas and carcinoidsand is especially useful to distinguish metastatic colorectal adenocarcinoma from lung adenocarcinoma.However, mucinous carcinomas of the ovary also express CDX2 protein. It limits the usefulness of this marker in the distinction of metastatic colorectal adenocarcinoma from mucinous carcinoma of the ovary. |
CDX2 Antibody |
|
V8501-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: The specificity of this monoclonal antibody to its intended target was validated by HuProtTMArray, containing more than 19,000, full-length human proteins.The intestine-specific transcription factors CDX1 and CDX2 are important for directing intestinal development, differentiation, proliferation and maintenance of the intestinal phenotype. CDX2 protein expression has been seen in GI carcinomas. Anti-CDX2 has been useful to establish GI origin of metastatic adenocarcinomas and carcinoidsand is especially useful to distinguish metastatic colorectal adenocarcinoma from lung adenocarcinoma.However, mucinous carcinomas of the ovary also express CDX2 protein. It limits the usefulness of this marker in the distinction of metastatic colorectal adenocarcinoma from mucinous carcinoma of the ovary. |
CDX2 Antibody |
|
V8501SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: The specificity of this monoclonal antibody to its intended target was validated by HuProtTMArray, containing more than 19,000, full-length human proteins.The intestine-specific transcription factors CDX1 and CDX2 are important for directing intestinal development, differentiation, proliferation and maintenance of the intestinal phenotype. CDX2 protein expression has been seen in GI carcinomas. Anti-CDX2 has been useful to establish GI origin of metastatic adenocarcinomas and carcinoidsand is especially useful to distinguish metastatic colorectal adenocarcinoma from lung adenocarcinoma.However, mucinous carcinomas of the ovary also express CDX2 protein. It limits the usefulness of this marker in the distinction of metastatic colorectal adenocarcinoma from mucinous carcinoma of the ovary. |
CDX2 Antibody |
|
V3415-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: The intestine-specific transcription factors CDX1 and CDX2 are important for directing intestinal development, differentiation, proliferation and maintenance of the intestinal phenotype. CDX2 protein expression has been seen in GI carcinomas. Anti-CDX2 has been useful to establish GI origin of metastatic adenocarcinomas and carcinoids and is especially useful to distinguish metastatic colorectal adenocarcinoma from lung adenocarcinoma. However, mucinous carcinomas of the ovary also express CDX2 protein. It limits the usefulness of this marker in the distinction of metastatic colorectal adenocarcinoma from mucinous carcinoma of the ovary. |
CDX2 Antibody |
|
V3415-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: The intestine-specific transcription factors CDX1 and CDX2 are important for directing intestinal development, differentiation, proliferation and maintenance of the intestinal phenotype. CDX2 protein expression has been seen in GI carcinomas. Anti-CDX2 has been useful to establish GI origin of metastatic adenocarcinomas and carcinoids and is especially useful to distinguish metastatic colorectal adenocarcinoma from lung adenocarcinoma. However, mucinous carcinomas of the ovary also express CDX2 protein. It limits the usefulness of this marker in the distinction of metastatic colorectal adenocarcinoma from mucinous carcinoma of the ovary. |
CDX2 Antibody |
|
V3415SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: The intestine-specific transcription factors CDX1 and CDX2 are important for directing intestinal development, differentiation, proliferation and maintenance of the intestinal phenotype. CDX2 protein expression has been seen in GI carcinomas. Anti-CDX2 has been useful to establish GI origin of metastatic adenocarcinomas and carcinoids and is especially useful to distinguish metastatic colorectal adenocarcinoma from lung adenocarcinoma. However, mucinous carcinomas of the ovary also express CDX2 protein. It limits the usefulness of this marker in the distinction of metastatic colorectal adenocarcinoma from mucinous carcinoma of the ovary. |
CDX2 Antibody |
|
V3964-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: The intestine-specific transcription factors CDX1 and CDX2 are important for directing intestinal development, differentiation, proliferation and maintenance of the intestinal phenotype. CDX2 protein expression has been seen in GI carcinomas. Anti-CDX2 has been useful to establish GI origin of metastatic adenocarcinomas and carcinoids and is especially useful to distinguish metastatic colorectal adenocarcinoma from lung adenocarcinoma. However, mucinous carcinomas of the ovary also express CDX2 protein. It limits the usefulness of this marker in the distinction of metastatic colorectal adenocarcinoma from mucinous carcinoma of the ovary. |
CDX2 Antibody |
|
V3964-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: The intestine-specific transcription factors CDX1 and CDX2 are important for directing intestinal development, differentiation, proliferation and maintenance of the intestinal phenotype. CDX2 protein expression has been seen in GI carcinomas. Anti-CDX2 has been useful to establish GI origin of metastatic adenocarcinomas and carcinoids and is especially useful to distinguish metastatic colorectal adenocarcinoma from lung adenocarcinoma. However, mucinous carcinomas of the ovary also express CDX2 protein. It limits the usefulness of this marker in the distinction of metastatic colorectal adenocarcinoma from mucinous carcinoma of the ovary. |
CDX2 Antibody |
|
V3964IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: The intestine-specific transcription factors CDX1 and CDX2 are important for directing intestinal development, differentiation, proliferation and maintenance of the intestinal phenotype. CDX2 protein expression has been seen in GI carcinomas. Anti-CDX2 has been useful to establish GI origin of metastatic adenocarcinomas and carcinoids and is especially useful to distinguish metastatic colorectal adenocarcinoma from lung adenocarcinoma. However, mucinous carcinomas of the ovary also express CDX2 protein. It limits the usefulness of this marker in the distinction of metastatic colorectal adenocarcinoma from mucinous carcinoma of the ovary. |
CDX2 Antibody |
|
V3964SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: The intestine-specific transcription factors CDX1 and CDX2 are important for directing intestinal development, differentiation, proliferation and maintenance of the intestinal phenotype. CDX2 protein expression has been seen in GI carcinomas. Anti-CDX2 has been useful to establish GI origin of metastatic adenocarcinomas and carcinoids and is especially useful to distinguish metastatic colorectal adenocarcinoma from lung adenocarcinoma. However, mucinous carcinomas of the ovary also express CDX2 protein. It limits the usefulness of this marker in the distinction of metastatic colorectal adenocarcinoma from mucinous carcinoma of the ovary. |
CDX2 Antibody |
|
V7660-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: The intestine-specific transcription factors CDX1 and CDX2 are important for directing intestinal development, differentiation, proliferation and maintenance of the intestinal phenotype. CDX2 protein expression has been seen in GI carcinomas. Anti-CDX2 has been useful to establish GI origin of metastatic adenocarcinomas and carcinoidsand is especially useful to distinguish metastatic colorectal adenocarcinoma from lung adenocarcinoma.However, mucinous carcinomas of the ovary also express CDX2 protein. It limits the usefulness of this marker in the distinction of metastatic colorectal adenocarcinoma from mucinous carcinoma of the ovary. |
CDX2 Antibody |
|
V7660-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: The intestine-specific transcription factors CDX1 and CDX2 are important for directing intestinal development, differentiation, proliferation and maintenance of the intestinal phenotype. CDX2 protein expression has been seen in GI carcinomas. Anti-CDX2 has been useful to establish GI origin of metastatic adenocarcinomas and carcinoidsand is especially useful to distinguish metastatic colorectal adenocarcinoma from lung adenocarcinoma.However, mucinous carcinomas of the ovary also express CDX2 protein. It limits the usefulness of this marker in the distinction of metastatic colorectal adenocarcinoma from mucinous carcinoma of the ovary. |
CDX2 Antibody |
|
V7660SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: The intestine-specific transcription factors CDX1 and CDX2 are important for directing intestinal development, differentiation, proliferation and maintenance of the intestinal phenotype. CDX2 protein expression has been seen in GI carcinomas. Anti-CDX2 has been useful to establish GI origin of metastatic adenocarcinomas and carcinoidsand is especially useful to distinguish metastatic colorectal adenocarcinoma from lung adenocarcinoma.However, mucinous carcinomas of the ovary also express CDX2 protein. It limits the usefulness of this marker in the distinction of metastatic colorectal adenocarcinoma from mucinous carcinoma of the ovary. |
CDX2 Antibody |
|
V7661-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: The intestine-specific transcription factors CDX1 and CDX2 are important for directing intestinal development, differentiation, proliferation and maintenance of the intestinal phenotype. CDX2 protein expression has been seen in GI carcinomas. Anti-CDX2 has been useful to establish GI origin of metastatic adenocarcinomas and carcinoidsand is especially useful to distinguish metastatic colorectal adenocarcinoma from lung adenocarcinoma.However, mucinous carcinomas of the ovary also express CDX2 protein. It limits the usefulness of this marker in the distinction of metastatic colorectal adenocarcinoma from mucinous carcinoma of the ovary. |
CDX2 Antibody |
|
V7661-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: The intestine-specific transcription factors CDX1 and CDX2 are important for directing intestinal development, differentiation, proliferation and maintenance of the intestinal phenotype. CDX2 protein expression has been seen in GI carcinomas. Anti-CDX2 has been useful to establish GI origin of metastatic adenocarcinomas and carcinoidsand is especially useful to distinguish metastatic colorectal adenocarcinoma from lung adenocarcinoma.However, mucinous carcinomas of the ovary also express CDX2 protein. It limits the usefulness of this marker in the distinction of metastatic colorectal adenocarcinoma from mucinous carcinoma of the ovary. |
CDX2 Antibody |
|
V7661SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: The intestine-specific transcription factors CDX1 and CDX2 are important for directing intestinal development, differentiation, proliferation and maintenance of the intestinal phenotype. CDX2 protein expression has been seen in GI carcinomas. Anti-CDX2 has been useful to establish GI origin of metastatic adenocarcinomas and carcinoidsand is especially useful to distinguish metastatic colorectal adenocarcinoma from lung adenocarcinoma.However, mucinous carcinomas of the ovary also express CDX2 protein. It limits the usefulness of this marker in the distinction of metastatic colorectal adenocarcinoma from mucinous carcinoma of the ovary. |
CDX2 Antibody |
|
V8630-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: The specificity of this monoclonal antibody to its intended target was validated by HuProtTM Array, containing more than 19,000, full-length human proteins. The intestine-specific transcription factors CDX1 and CDX2 are important for directing intestinal development, differentiation, proliferation and maintenance of the intestinal phenotype. CDX2 protein expression has been seen in GI carcinomas. Anti-CDX2 has been useful to establish GI origin of metastatic adenocarcinomas and carcinoidsand is especially useful to distinguish metastatic colorectal adenocarcinoma from lung adenocarcinoma.However, mucinous carcinomas of the ovary also express CDX2 protein. It limits the usefulness of this marker in the distinction of metastatic colorectal adenocarcinoma from mucinous carcinoma of the ovary. |
CDX2 Antibody |
|
V8630-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: The specificity of this monoclonal antibody to its intended target was validated by HuProtTM Array, containing more than 19,000, full-length human proteins. The intestine-specific transcription factors CDX1 and CDX2 are important for directing intestinal development, differentiation, proliferation and maintenance of the intestinal phenotype. CDX2 protein expression has been seen in GI carcinomas. Anti-CDX2 has been useful to establish GI origin of metastatic adenocarcinomas and carcinoidsand is especially useful to distinguish metastatic colorectal adenocarcinoma from lung adenocarcinoma.However, mucinous carcinomas of the ovary also express CDX2 protein. It limits the usefulness of this marker in the distinction of metastatic colorectal adenocarcinoma from mucinous carcinoma of the ovary. |
CDX2 Antibody |
|
V8630SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: The specificity of this monoclonal antibody to its intended target was validated by HuProtTM Array, containing more than 19,000, full-length human proteins. The intestine-specific transcription factors CDX1 and CDX2 are important for directing intestinal development, differentiation, proliferation and maintenance of the intestinal phenotype. CDX2 protein expression has been seen in GI carcinomas. Anti-CDX2 has been useful to establish GI origin of metastatic adenocarcinomas and carcinoidsand is especially useful to distinguish metastatic colorectal adenocarcinoma from lung adenocarcinoma.However, mucinous carcinomas of the ovary also express CDX2 protein. It limits the usefulness of this marker in the distinction of metastatic colorectal adenocarcinoma from mucinous carcinoma of the ovary. |
CDX2 Antibody |
|
V9367-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
|
Description: The intestine-specific transcription factors CDX1 and CDX2 are important for directing intestinal development, differentiation, proliferation and maintenance of the intestinal phenotype. CDX2 protein expression has been seen in GI carcinomas. Anti-CDX2 has been useful to establish GI origin of metastatic adenocarcinomas and carcinoids and is especially useful to distinguish metastatic colorectal adenocarcinoma from lung adenocarcinoma. However, mucinous carcinomas of the ovary also express CDX2 protein. It limits the usefulness of this marker in the distinction of metastatic colorectal adenocarcinoma from mucinous carcinoma of the ovary. |
CDX2 Antibody |
|
V9367-20UG |
NSJ Bioreagents |
20ug |
EUR 219 |
|
Description: The intestine-specific transcription factors CDX1 and CDX2 are important for directing intestinal development, differentiation, proliferation and maintenance of the intestinal phenotype. CDX2 protein expression has been seen in GI carcinomas. Anti-CDX2 has been useful to establish GI origin of metastatic adenocarcinomas and carcinoids and is especially useful to distinguish metastatic colorectal adenocarcinoma from lung adenocarcinoma. However, mucinous carcinomas of the ovary also express CDX2 protein. It limits the usefulness of this marker in the distinction of metastatic colorectal adenocarcinoma from mucinous carcinoma of the ovary. |
CDX2 Antibody |
|
V9367SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
|
Description: The intestine-specific transcription factors CDX1 and CDX2 are important for directing intestinal development, differentiation, proliferation and maintenance of the intestinal phenotype. CDX2 protein expression has been seen in GI carcinomas. Anti-CDX2 has been useful to establish GI origin of metastatic adenocarcinomas and carcinoids and is especially useful to distinguish metastatic colorectal adenocarcinoma from lung adenocarcinoma. However, mucinous carcinomas of the ovary also express CDX2 protein. It limits the usefulness of this marker in the distinction of metastatic colorectal adenocarcinoma from mucinous carcinoma of the ovary. |
 Antibody) Polyclonal Phospho-CDX2(S283) Antibody |
|
APR05228G |
Leading Biology |
0.1ml |
EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Phospho-CDX2(S283) . This antibody is tested and proven to work in the following applications: |
) Polyclonal CDX2 Antibody (aa1-60) |
|
APR02980G |
Leading Biology |
0.05mg |
EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CDX2 (aa1-60). This antibody is tested and proven to work in the following applications: |
) Polyclonal CDX2 Antibody (C-Terminus) |
|
APR03229G |
Leading Biology |
0.05mg |
EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CDX2 (C-Terminus). This antibody is tested and proven to work in the following applications: |
 Polyclonal Goat Anti-CDX2 Antibody |
|
APR16249G |
Leading Biology |
0.1 mg |
EUR 580.8 |
|
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-CDX2 . This antibody is tested and proven to work in the following applications: |
 (CDX2/1690) Antibody) CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNC941690-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),CF594 conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNC941690-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),CF594 conjugate, Concentration: 0.1mg/mL |
 (CDX2/2951R) Antibody) CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNC942951-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), CF594 conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNC942951-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), CF594 conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNCA1690-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),APC conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNCA2951-250 |
Biotium |
250uL |
EUR 472.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), APC conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNC551690-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),CF555 conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNC551690-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),CF555 conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNC552951-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), CF555 conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNC552951-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), CF555 conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNC611690-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),CF660R conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNC611690-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),CF660R conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNC612951-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), CF660R conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNC612951-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), CF660R conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNUM1690-50 |
Biotium |
50uL |
EUR 474 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690), 1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNCP1690-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),PerCP conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNCP2951-250 |
Biotium |
250uL |
EUR 472.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), PerCP conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNCR1690-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),RPE conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNCR2951-250 |
Biotium |
250uL |
EUR 472.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), RPE conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNC402951-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), CF640R conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNC402951-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), CF640R conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNC431690-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),CF543 conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNC431690-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),CF543 conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNC432951-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), CF543 conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNC432951-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), CF543 conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNC051690-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),CF405M conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNC051690-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),CF405M conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNC052951-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), CF405M conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNC052951-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), CF405M conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNC401690-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),CF640R conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNC401690-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),CF640R conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNC811690-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),CF680R conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNC811690-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),CF680R conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNC812951-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), CF680R conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNC812951-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), CF680R conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNC801690-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),CF680 conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNC801690-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),CF680 conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNC802951-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), CF680 conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNC802951-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), CF680 conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNCH1690-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNCH1690-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNCH2951-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNCH2951-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNUB2951-100 |
Biotium |
100uL |
EUR 316.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), Concentration: 0.2mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNUB2951-50 |
Biotium |
50uL |
EUR 486 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), 1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNUB2951-500 |
Biotium |
500uL |
EUR 615.6 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), Concentration: 0.2mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNC041690-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),CF405S conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNC041690-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),CF405S conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNC042951-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), CF405S conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNC042951-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), CF405S conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNC681690-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),CF568 conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNC681690-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),CF568 conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNC682951-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), CF568 conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNC682951-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), CF568 conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNC701690-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),CF770 conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNC701690-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),CF770 conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNC702951-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), CF770 conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNC702951-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), CF770 conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNCAP1690-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNCAP1690-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNCAP2951-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNCAP2951-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNC881690-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),CF488A conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNC881690-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),CF488A conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNC882951-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), CF488A conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNC882951-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), CF488A conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNC472951-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), CF647 conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNC472951-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), CF647 conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNCB1690-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),Biotin conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNCB1690-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),Biotin conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNCB2951-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), Biotin conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/2951R) Antibody |
|
BNCB2951-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/2951R), Biotin conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNC471690-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),CF647 conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNC471690-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690),CF647 conjugate, Concentration: 0.1mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNUB1690-100 |
Biotium |
100uL |
EUR 250.8 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690), Concentration: 0.2mg/mL |
CDX2 (GI Epithelial Marker) (CDX2/1690) Antibody |
|
BNUB1690-500 |
Biotium |
500uL |
EUR 549.6 |
|
Description: Primary antibody against CDX2 (GI Epithelial Marker) (CDX2/1690), Concentration: 0.2mg/mL |
 Polyclonal Conjugated Antibody) CDX2 (Phospho-Ser283) Polyclonal Conjugated Antibody |
|
C12584 |
SAB |
100ul |
EUR 476.4 |
 Cdx2 Conjugated Antibody |
|
C21644 |
SAB |
100ul |
EUR 476.4 |
 CDX2 Conjugated Antibody |
|
C43449 |
SAB |
100ul |
EUR 476.4 |
 anti- CDX2 antibody |
|
FNab01573 |
FN Test |
100µg |
EUR 658.5 |
|
|
|
Description: Antibody raised against CDX2 |
 CDX2 Monoclonal Antibody |
|
EM1057-100ul |
ELK Biotech |
100ul |
EUR 334.8 |
|
Description: A Mouse Monoclonal antibody against CDX2 from Human/ Rat/ Mouse. This antibody is tested and validated for WB, ELISA, IHC |
CDX2 Monoclonal Antibody |
|
EM1057-50ul |
ELK Biotech |
50ul |
EUR 248.4 |
|
Description: A Mouse Monoclonal antibody against CDX2 from Human/ Rat/ Mouse. This antibody is tested and validated for WB, ELISA, IHC |
CDX2 Monoclonal Antibody |
|
27189-100ul |
SAB |
100ul |
EUR 302.4 |
CDX2 Monoclonal Antibody |
|
27189-50ul |
SAB |
50ul |
EUR 224.4 |
CDX2 Monoclonal Antibody |
|
27190-100ul |
SAB |
100ul |
EUR 302.4 |
CDX2 Monoclonal Antibody |
|
27190-50ul |
SAB |
50ul |
EUR 224.4 |
 Antibody) CDX2 (pS283) Antibody |
|
abx149177-100ug |
Abbexa |
100 ug |
EUR 526.8 |
|
|
CDX2 (pS283) Antibody |
|
abx032079-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
|
CDX2 (pS283) Antibody |
|
abx032079-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
|
CDX2 Monoclonal Antibody |
|
ABM40057-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
|
|
Description: A monoclonal antibody for detection of CDX2 from Human, Mouse, Rat. This CDX2 antibody is for WB, IF, IHC-P. It is affinity-purified from mouse ascites by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in mouse by using as an immunogen synthetic peptide |
CDX2 Monoclonal Antibody |
|
ABM40057-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
|
|
Description: A monoclonal antibody for detection of CDX2 from Human, Mouse, Rat. This CDX2 antibody is for WB, IF, IHC-P. It is affinity-purified from mouse ascites by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in mouse by using as an immunogen synthetic peptide |
CDX2 Monoclonal Antibody |
|
ABM40057-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
|
|
Description: A monoclonal antibody for detection of CDX2 from Human, Mouse, Rat. This CDX2 antibody is for WB, IF, IHC-P. It is affinity-purified from mouse ascites by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in mouse by using as an immunogen synthetic peptide |
 Anti-Cdx2 Antibody |
|
A00877 |
BosterBio |
100ul |
EUR 476.4 |
|
Description: Rabbit Polyclonal Cdx2 Antibody. Validated in WB and tested in Mouse, Rat. |
 Monoclonal CDX2 Antibody |
|
AMM03166G |
Leading Biology |
0.1ml |
EUR 580.8 |
|
Description: A Monoclonal antibody against Human CDX2. The antibodies are raised in Mouse. This antibody is applicable in WB, ICC, IP |
